Home > PS Ratio > SAKAR HEALTHCARE

SAKAR HEALTHCARE
PS (Price/Sales) Ratio

The Current P/S Ratio of SAKAR HEALTHCARE is 5.11.

Share Price ₹355.5Apr 26,2024
Market Cap ₹771.3 Cr
Sales-TTM₹150.9 CrTTM-Consolidated Results
Price/Sales5.11xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results
SAKAR HEALTHCARE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of SAKAR HEALTHCARE

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SAKAR HEALTHCARE is calculated as :

Current Market Cap [ ₹771.3 Cr] as on Apr 26,2024

(/) Sales [ ₹150.9 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 5.11x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay '5.11 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SAKAR HEALTHCARE !

The chart below summarizes the trend in P/S Ratio of SAKAR HEALTHCARE over the last five years.

Historical PS (Price/Sales) ratio chart of SAKAR HEALTHCARE


PS Ratio Performance Analysis for SAKAR HEALTHCARE

- SAKAR HEALTHCARE 's latest p/e ratio is 5.11x.

- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2023 to Mar2020 averaged 1.86x.

- SAKAR HEALTHCARE 's operated at median p/e ratio of 1.86x from fiscal years ending March 2018 to 2022.

- Looking back at the last 4 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2023 at 2.86x.

- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 0.9x.


How does SAKAR HEALTHCARE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SAKAR HEALTHCARE 150.95.11771.3
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.67.61360,920.0
CIPLA LTD25,350.24.49113,794.0
DR REDDYS LABORATORIES LTD27,212.53.83104,316.0
ZYDUS LIFESCIENCES LTD19,024.25.0195,380.9
DIVIS LABORATORIES LTD7,492.814.26106,860.0
MANKIND PHARMA LTD9,946.39.5494,869.4
TORRENT PHARMACEUTICALS LTD10,474.08.6991,057.0
LUPIN LTD19,480.13.7873,642.4
AUROBINDO PHARMA LTD27,894.72.3866,278.5
ABBOTT INDIA LTD5,753.49.5554,961.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SAKAR HEALTHCARE 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.38x
Max industry PS 14.26x
Median industry PS 5.11x
Average industry PS 6.75x



You may also like the below Video Courses